Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Zimmer Biomet Holdings Inc

ZBH
98,0468
-0,9332 (-0,94%)
13 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/2/202523:22EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
11/2/202514:33EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/2/202512:30EDGAR2Form 8-K - Current report
06/2/202512:30PRNUSZimmer Biomet Announces Fourth Quarter and Full-Year 2024..
31/1/202522:25PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
29/1/202512:40EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
29/1/202512:34EDGAR2Form 8-K - Current report
28/1/202523:59PRNUSZimmer Biomet Announces Definitive Agreement to Acquire..
16/1/202513:30PRNUSZimmer Biomet Announces Webcast and Conference Call of..
03/1/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202413:30PRNUSZimmer Biomet to Present at the 43rd Annual J.P. Morgan..
18/12/202413:00PRNUSZimmer Biomet Announces Quarterly Dividend for Fourth..
13/12/202413:30PRNUSZimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless..
04/12/202413:30PRNUSZimmer Biomet Receives FDA Clearance for Persona® SoluTion™..
25/11/202422:05PRNUSZimmer Biomet Receives FDA Approval for Oxford® Cementless..
22/11/202415:37EDGAR2Form CERT - Certification by an exchange approving..
21/11/202413:30PRNUSZimmer Biomet to Present at Citi's 2024 Global Healthcare..
20/11/202422:35EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
20/11/202422:10EDGAR2Form 8-K - Current report
19/11/202422:15EDGAR2Form 8-K - Current report
14/11/202422:46EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/11/202422:15EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
13/11/202413:30PRNUSZimmer Biomet Welcomes Arnold Schwarzenegger as Chief..
13/11/202412:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/11/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202413:30PRNUSZimmer Biomet to Present at Jefferies London Healthcare..
30/10/202421:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202411:30EDGAR2Form 8-K - Current report
30/10/202411:30PRNUSZimmer Biomet Announces Third Quarter 2024 Financial Results
28/10/202412:30PRNUSZimmer Biomet to Debut New Z1™ Femoral Hip System and..
09/10/202413:30PRNUSZimmer Biomet Announces Webcast and Conference Call of Third..
02/10/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202413:30PRNUSZimmer Biomet Names David DeMartino as Senior Vice..
29/8/202422:43PRNUSZimmer Biomet Announces Quarterly Dividend for Third Quarter..
21/8/202413:30PRNUSZimmer Biomet to Present at the Wells Fargo 2024 and Morgan..
15/8/202422:16EDGAR2Form 8-K - Current report
14/8/202422:16EDGAR2Form 8-K - Current report
09/8/202423:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/8/202414:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/8/202412:30EDGAR2Form 8-K - Current report
07/8/202412:30PRNUSZimmer Biomet Announces Second Quarter 2024 Financial..
08/7/202413:30PRNUSZimmer Biomet Announces Webcast and Conference Call of..
Apertura: 98,41 Min: 97,69 Max: 99,50
Chiusura: 98,98

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network